Canada House reports record revenues for the 15 months ended July 31, 2022

Canada House Cannabis Group Inc. reported its financial results for the 15 months ending July 31, 2022 on Monday.

The company reported record revenues for both the recreational and medical cannabis segments.

It's a trend that we expect to continue and will directly affect CHV's bottom line as we make further progress to optimize our low-cost cultivation at CHV's wholly owned subsidiary, IsoCanMed Inc., said Chris Churchill-Smith, CEO of Canada House.

Financial Highlights For The 15 Month Period

Loss and complete loss for the 15 month period was at CA $11.09 million, an improvement of CA $272 000 or 2% compared to a loss of CA $11.36 million during the year ending April 30, 2021.

EBITDA of CA $83 000 of loss, an improvement of $679 or 89%, compared to CA $762 000 for the three months ended July 31, 2021, is an improvement of $679 or 89%.